European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 146, Issue 2 , Pages 180-183 , October 2009

Does fetal fibronectin testing change patient management in women at risk of preterm labour?

Received 4 March 2009 ,Revised 1 June 2009 ,Accepted 18 June 2009.

References 

  1. Slattery M, Morrison J. Preterm delivery. Lancet. 2002;9344:1489–1497
  2. Larroque B, Ancel P-Y, Marret S, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet. 2008;371:813–820
  3. Creasy RK, Gummer BA, Liggins GC. System for predicting spontaneous preterm birth. Obstet Gynecol. 1980;55:692–695
  4. Goldenberg RL, Goepfert AR, Ramsey PS. Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol. 2005;192:S36–46
  5. Goldenberg RL, Iams JD, Mercer BF M, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health. 1998;88:233–238
  6. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84
  7. Peaceman AM, Andrews WW, Thorp JM, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol. 1997;177(1):13–18
  8. Abenhaim H, Morin L, Benjamin A. Does availability of fetal fibronectin testing in the management of threatened preterm labour affect the utilization of hospital resources?. Can J Obstet Gynaecol. 2005;27:689–694
  9. Tanir HM, Sener T, Yildiz Z. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study. Clin Exp Obstet Gynecol. 2008;35:61–64
  10. Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 1991;325:669–674
  11. Smith V, Devane D, Begley C, Clarke M, Higgins S. A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol. 2007;133:134–142
  12. Joffe GM, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol. 1999;180:581–586
  13. Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev. 2008;(Issue 4):Art. No:CD006843
  14. Grobman WA, Welshman EE, Calhoun EA. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behaviour and health care costs? A randomized trial. Am J Obstet Gynecol. 2004;191:235–240

☆ Poster Presentation at the Royal College of Obstetricians and Gynaecologists 7th International Scientific Meeting, Montreal, Canada. 17–20 September 2008.

PII: S0301-2115(09)00430-8

doi: 10.1016/j.ejogrb.2009.06.021

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 146, Issue 2 , Pages 180-183 , October 2009

Article Tools

* Image Usage & Resolution